Keywords: remicade, label, extended, usa, johnson, schering-plough, infliximab

Remicade label extended in USA

Article | 08 July 2002

Print This

Johnson & Johnson and Schering-Plough's Remicade (infliximab) hasbecome the first biologic therapy to be approved by the US Food and Drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in